Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Sanofi started—and lost—$28B bidding war for Horizon

<< Previous

Bullboard Posts

Next >>

Comment by Infinityon Dec 12, 2022 10:08pm

254 Views

Post# 35167569

RE:RE:Sanofi started—and lost—$28B bidding war for Horizon

Horizon Pharma share holders got about 30% more for their shares prior to the first offer from Sanofi. About $90 to $ 116.50 offer from Amgen. I think it is too early to think about sale or JV

<< Previous

Bullboard Posts

Next >>

AI companies to invest in